Scirrhous Carcinoma

This is a specific type of lung cancer called adenocarcinoma. The name 'scirrhous' means it has a hard, firm texture. This happens because the cancer cells grow into dense scar tissue (fibrous tissue) in the lung.

Condition

What people with Scirrhous Carcinoma report

Every report comes from a Lived member, sent anonymously.

NameHow it went

No reports yet

Add what worked for you with the search bar below

About Scirrhous Carcinoma

What It Is

Scirrhous carcinoma is a cancer of gland-forming cells (an adenocarcinoma) that makes the tissue around it unusually hard. The name comes from the Greek word for hard. As the cancer cells spread, they trigger the growth of dense scar-like fibrous tissue, and that tissue stiffens and shrinks the organ involved. The term is a description a pathologist uses, and it has been applied to tumors in several organs. In everyday medical practice it most often refers to a form of stomach cancer. Instead of forming a lump or ulcer, the cancer cells spread loosely through the layers of the stomach wall, often underneath a lining that looks normal. Over time the wall becomes thick and rigid, and the stomach can no longer stretch to hold food. When this involves much of the stomach, it is called linitis plastica, sometimes described as a leather bottle stomach. Doctors also use the names diffuse-type gastric cancer and Borrmann type 4 gastric cancer for closely related patterns. This form matters because it tends to grow quietly, is hard to see and sample, and spreads early to the lining of the abdomen. As a result, it is often found later and is harder to treat than other stomach cancers.

Causes & Risk Factors

There is usually no single identifiable cause. The cancer cells typically lose a protein called E-cadherin, which normally helps neighboring cells stick together. Without it, cells drift apart and creep through the stomach wall rather than forming a solid mass, while signals from the cancer drive the surrounding fibrous scarring. In a small share of people, the risk is inherited. Hereditary diffuse gastric cancer is a family syndrome most often caused by a change in the CDH1 gene, which makes E-cadherin, and less often in a related gene, CTNNA1. People who carry one of these changes have a high lifetime chance of diffuse stomach cancer, often at a younger age than usual, and women also have a higher risk of lobular breast cancer. A family history of stomach cancer, especially at a young age, or of both stomach cancer and lobular breast cancer, is a reason to ask about genetic counseling. General risk factors for stomach cancer include long-term Helicobacter pylori (H. pylori) infection of the stomach, chronic stomach inflammation, smoking, and a diet high in salted, smoked or pickled foods. How strongly each applies to this diffuse form specifically is less clear. Unlike most stomach cancers, which mainly affect older adults, linitis plastica is seen relatively more often in women and in younger adults.

How It's Diagnosed

Evaluation usually starts with symptoms, a physical exam, a review of personal and family history, and blood tests that can show anemia from slow bleeding. The key test is an upper endoscopy, in which a thin, lighted tube is passed through the mouth to look inside the stomach and take tissue samples (biopsies) for a pathologist to examine. This form of cancer is notoriously easy to miss. Because it spreads beneath the surface, the lining can look normal or only mildly inflamed, and small surface biopsies may contain no cancer cells even when the cancer is present. Clues that raise suspicion include thickened, stiff folds and a stomach that does not expand when air is gently pumped in during endoscopy. When the suspicion is strong, doctors may take deeper or repeat biopsies, use endoscopic ultrasound (an ultrasound probe on the endoscope that measures how thick each layer of the wall is), or order a barium x-ray series that shows the stomach's overall shape. Once cancer is confirmed, staging tests show how far it has spread. A CT scan, and sometimes a PET-CT scan, looks for spread to lymph nodes and other organs. Because this cancer often spreads in tiny deposits across the lining of the abdomen (the peritoneum) that scans can miss, many people also have a staging laparoscopy, a keyhole operation to look inside the abdomen and wash the area to check for cancer cells. The tumor sample is also tested for biomarkers, proteins and genetic features on the cancer cells such as HER2, PD-L1, mismatch repair status and claudin 18.2, because the results determine which targeted and immune treatments may help.

Treatment Options

Treatment depends on whether the cancer can be completely removed, how far it has spread and a person's overall health. Because this cancer tends to spread into the lining of the abdomen early, it often behaves like a whole-body disease even when scans show it only in the stomach. For that reason, plans usually combine surgery with medicines that reach cancer cells throughout the body, and are best made by a team experienced in stomach cancer. When the cancer appears confined to the stomach area, the main operation is a gastrectomy, the removal of part or, more often for this diffuse form, all of the stomach, along with nearby lymph nodes. The surgeon then joins the esophagus to the small intestine so that eating remains possible. Chemotherapy is commonly given before and after surgery to shrink the cancer and lower the risk of it returning, and immunotherapy may be added in some plans. Evidence specific to this form is limited: one large trial found that a particular chemotherapy combination given before surgery did not improve survival compared with going straight to surgery, which is part of why newer combinations are being studied. When the cancer has already spread or cannot be removed, treatment aims to control it, ease symptoms and extend life. Chemotherapy is the foundation, and biomarker results guide what is added. Immunotherapy drugs such as nivolumab (Opdivo) or pembrolizumab (Keytruda) help the immune system attack the cancer. For tumors that test positive for claudin 18.2, a protein found fairly often in diffuse stomach cancers, zolbetuximab (Vyloy), an antibody that targets that protein, can be added to first-line chemotherapy; nausea and vomiting are its most noticeable side effects. HER2-targeted drugs such as trastuzumab (Herceptin) are used when tumors are HER2 positive, which is less common in this form. If the stiffened stomach or a tumor blocks food from passing, procedures such as a stent (a small expandable tube) or a bypass operation can restore eating. Nutrition support, pain control and palliative care, which focuses on comfort and quality of life, are part of good treatment at every stage. Clinical trials are worth asking about, including studies of heated chemotherapy delivered directly into the abdomen. For people who carry a CDH1 change but have no known cancer, the options are regular specialized endoscopy with many biopsies or removal of the stomach before cancer develops (prophylactic total gastrectomy). This is a major decision best made with a genetics team and an experienced surgeon.

What to Expect

The outlook for this form of stomach cancer is generally poorer than for other stomach cancers, mainly because it is often found late and tends to return in the lining of the abdomen even after successful surgery. Outcomes vary widely, though. People whose cancer is found early, while it is still confined to the stomach, do considerably better, and newer biomarker-guided and immune treatments have widened the options for advanced disease. Your care team can explain what the stage and test results mean for you. Life after a total gastrectomy involves a lasting change in how you eat. Without a stomach to store food, most people need to eat small, frequent, nutrient-dense meals, limit added sugars and drink fluids separately from meals. Some people get dumping syndrome, in which food moves into the intestine too quickly and causes cramping, sweating, lightheadedness or diarrhea after eating. Weight loss is common, and lifelong vitamin and mineral supplements, including vitamin B12 injections or high-dose supplements, are needed to prevent deficiencies. A dietitian is an important part of recovery, and eating usually becomes more manageable over months, although some restrictions persist. Treatment with chemotherapy can bring fatigue, nausea, appetite loss and a higher risk of infection, and the illness itself can make eating hard. After treatment, follow-up visits, scans and sometimes blood tests check for return of the cancer and for nutritional problems. Living with this diagnosis, or with the decision about preventive surgery, can take a real emotional toll, and counseling and support groups help many people and families.

When to Seek Help

See a doctor if you have indigestion, upper abdominal discomfort, feeling full after small meals, loss of appetite or unexplained weight loss that lasts more than a few weeks, especially if you have a family history of stomach cancer. If symptoms continue after an endoscopy that found nothing, go back and ask whether further testing is needed, since this cancer can be missed on a first look. People with a family history of early stomach cancer or lobular breast cancer should ask about genetic counseling. Contact your care team the same day if you cannot keep food or fluids down, vomit repeatedly after eating, notice black or bloody stools, develop yellowing of the skin or eyes, or see your abdomen swelling. During chemotherapy, call your treatment team right away about a fever. Get emergency care for vomiting blood or material that looks like coffee grounds, heavy bleeding from the rectum, fainting, or sudden severe abdominal pain.

Questions to Ask Your Doctor

  1. 1.How sure are we of the diagnosis, and do I need deeper or repeat biopsies, endoscopic ultrasound or a staging laparoscopy?
  2. 2.What did the biomarker tests show, and which treatments do those results make available to me?
  3. 3.Is the goal of my treatment to cure the cancer or to control it, and what can I realistically expect from each option?
  4. 4.If I have my stomach removed, how will eating and nutrition change, and who will help me manage that?
  5. 5.Should my family members or I have genetic counseling or testing for hereditary diffuse gastric cancer?

Last reviewed • Oct 2026

Educational content, not medical advice.